ATI Invests $2M in Phagolum Sepsis Diagnostic Toolkit

kit.jpgPhagolum Ltd. is developing a diagnostic toolkit to detect sepsis, the leading cause of death in non-coronary ICU patients and the tenth most common cause of death overall. According to medical literature, “sepsis is characterized by a whole-body inflammatory state caused by infection” and is “broadly defined as the presence of various pus-forming and other pathogenic organisms, or their toxins, in the blood or tissues.”

Ashkelon Technological Industries (ATI), a tech incubator focused on healthcare and cleantech, will invest $2 million in the medical device start-up which was essentially borne out of research carried out at the National Institute for Biotechnology at Ben Gurion University. According to Globes “The diagnostic kit will enable the identification of the different sepsis stages, including early detection and will also be able to identify the cause of infection. The kit will contain biological reagents and proprietary software that will analyze the recorded data.”

More broadly, Phagolum is a fiber optic-based sensor that may be adapted to many potential applications, but mainly to medical diagnosis and prognosis including early detection. Get more info on the technology here.


One Response

  1. More than 215,000 people will die of sepsis in the United States each year, more than 750,000 will require hospital treatment, and the costs will be nearly $17 billion.
    Three of four patients presenting with clinically suspected severe sepsis have documented infection. However, patients with clinically suspected sepsis but without microbiological documentation and patients with documented infection share common risk factors and are at similarly high risk of death. In addition to the severity of illness score, acute organ failures and the characteristics of underlying diseases should be accounted for in stratification of patients and outcome analyses.
    Good luck to Ashkelon Technological Industries (ATI), who are working hard to make this successful.
    Raj Nihalani, MD, RAC(US)
    Irvine, Ca

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: